Litcius/Paper detail

A pilot randomized controlled trial of de novo belatacept-based immunosuppression following anti-thymocyte globulin induction in lung transplantation

Howard J. Huang, Kenneth B. Schechtman, Medhat Askar, Cory T. Bernadt, Brigitte Mittler, Peter Doré, Chad A. Witt, Derek E. Byers, Rodrigo Vazquez Guillamet, Laura Halverson, Ruben G. Nava, Varun Puri, Andrew E. Gelman, Daniel Kreisel, Ramsey R. Hachem

2022American Journal of Transplantation34 citationsDOIOpen Access PDF

Topics & Concepts

BelataceptMedicineImmunosuppressionPrednisoneTacrolimusTransplantationThymoglobulinMycophenolic acidAnti-thymocyte globulinKidney transplantationUrologyInternal medicineKidney transplantTransplantation: Methods and OutcomesRenal Transplantation Outcomes and TreatmentsOrgan Transplantation Techniques and Outcomes
A pilot randomized controlled trial of de novo belatacept-based immunosuppression following anti-thymocyte globulin induction in lung transplantation | Litcius